Cervical Cancer - Epidemiology Insights to 2023

  • ID: 4330793
  • Report
  • 40 pages
  • DelveInsight
1 of 3
Cervical Cancer - Epidemiology Insights-2023 reports provides an overview of the disease and the global historical and forecasted epidemiological data of the Cervical Cancer for the 7 major markets - United States, EU5(Germany, France, Italy, Spain and United Kingdom) and Japan for 2013-2023. According to Publisher, the incidence rate for Cervical Cancer and its subtypes from 2015 to 2023 will remain the same. However, the number of incident cases is expected to increase due to the increase in the total female population.

Cervical Cancer occurred due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus. Cervical Cancer is caused by inheritance of defects or mutation in genes. Cervical cancer is also caused due to the infection by the Human Papilloma Virus (HPV) which can infect cells on the surface of the skin and those lining the genitals, anus, mouth and throat, but not the blood or internal organs such as the heart or lungs.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Key Coverage and Benefits:
  • The report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
  • The report covers the detailed global historical and forecasted epidemiological data covering 7MM from 2013-2023.
Note: Please allow up to 48 hours for delivery of this report after payment has been made.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction

2. Disease Overview
  • Types of Cervical cancer
  • Staging of Cervical cancer
  • Pathophysiology
  • Etiology
  • Risk Factors
  • Diagnosis
3. Epidemiology and Patient Population

4. United States
  • Assumptions and Rationale
  • Incident Cases of Cervical Cancer in United States
  • Incident Cases of Cervical Cancer Diagnosed by Cancer Stage
5. Europe
5.1 United Kingdom (UK)
  • Assumptions and Rationale
  • Incident Cases of Cervical Cancer in United Kingdom (UK)
5.2 Germany (DE)
  • Assumptions and Rationale
  • Incident Cases of Cervical Cancer in Germany (DE)
5.3 Italy (IT)
  • Assumptions and Rationale
  • Incident Cases of Cervical Cancer in Italy (IT)
5.4 France (FR)
  • Assumptions and Rationale
  • Incident Cases of Cervical Cancer in France (FR)
5.6 Spain (SP)
  • Assumptions and Rationale
  • Incident Cases of Cervical Cancer in Spain (SP)
6. Japan (JP)
  • Assumptions and Rationale
  • Incident Cases of Cervical Cancer in Japan (JP)
7. Appendix

8. Report Methodology

9. Consulting Services

10. Disclaimer

11. About

List of Tables
Table 1: Incident Cases of Cervical Cancer in United States (2013-2023)
Table 2: Incident Cases of Cervical Cancer diagnosed by Cancer Stage, in United States (2013-2023)
Table 3: Incident Cases of Cervical Cancer in United Kingdom (2013-2023)
Table 4: Incident Cases of Cervical Cancer in Germany (2013-2023)
Table 5: Incident Cases of Cervical Cancer in Italy (2013-2023)
Table 6: Incident Cases of Cervical Cancer in France (2013-2023)
Table 7: Incident Cases of Cervical Cancer in Spain (2013-2023)
Table 8: Incident Cases of Cervical Cancer in Japan (2013-2023)

List of Figures
Figure 1: Pathophysiology of Cervical Cancer, 2017
Figure 2: Risk Factors of Cervical Cancer, 2017
Figure 3: Incident Cases of Cervical Cancer in United States (2013-2023)
Figure 4: Incident Cases of Cervical Cancer diagnosed by Cancer Stage, in United States (2013-2023)
Figure 5: Incident Cases of Cervical Cancer in United Kingdom (2013-2023)
Figure 6: Incident Cases of Cervical Cancer in Germany (2013-2023)
Figure 7: Incident Cases of Cervical Cancer in Italy (2013-2023)
Figure 8: Incident Cases of Cervical Cancer in France (2013-2023)
Figure 9: Incident Cases of Cervical Cancer in Spain (2013-2023)
Figure 10: Incident Cases of Cervical Cancer in Japan (2013-2023)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll